VCIT vs XLV
Vanguard Intermediate-Term Corporate Bond ETF vs Health Care Select Sector SPDR Fund
VCIT$82.08
Vanguard Intermediate-Term Corporate Bond ETF
Intermediate-term investment-grade corporate bonds.
Expense: 0.03%Yield: 4.78%
XLV$161.81
Health Care Select Sector SPDR Fund
S&P 500 health care sector.
Expense: 0.08%Yield: 1.60%
Quick take
- • VCIT has the lower expense ratio at 0.03% vs 0.08% for XLV.
- • VCIT pays a higher dividend yield (4.78%).
Side-by-side metrics
| Metric | VCIT | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.03% | 0.08% |
Dividend yield Trailing 12-month yield. | 4.78% | 1.60% |
AUM Assets under management — bigger funds are typically more liquid. | $69.44B | $40.60B |
YTD return | 0.05% | 5.74% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.07 | 0.51 |
P/E ratio | — | 29.12 |
Last price | $82.08 | $161.81 |
Inception | — | — |
Issuer | Vanguard | State Street |
VCIT top holdings
Holdings data unavailable for VCIT.
XLV top holdings
Top holdings · XLV
| LLY | Eli Lilly and Co | 16.48% |
| JNJ | Johnson & Johnson | 10.62% |
| ABBV | AbbVie Inc | 7.72% |
| UNH | UnitedHealth Group Inc | 6.56% |
| MRK | Merck & Co Inc | 5.51% |
| AMGN | Amgen Inc | 3.40% |
| TMO | Thermo Fisher Scientific Inc | 3.24% |
| ABT | Abbott Laboratories | 2.75% |
| GILD | Gilead Sciences Inc | 2.73% |
| ISRG | Intuitive Surgical Inc | 2.45% |
Sector breakdown · XLV
Healthcare100.0%
About VCIT
VCIT (Vanguard Intermediate-Term Corporate Bond ETF) is Intermediate-term investment-grade corporate bonds. Managed by Vanguard, the fund carries $69.4B in assets under management, an expense ratio of 0.03%, a dividend yield of 4.78%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $40.6B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.60%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.5% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.